ATE268166T1 - Zusammenstellungen zur behandlung von lungenkrankheiten mit optisch reinem s-salmeterol - Google Patents

Zusammenstellungen zur behandlung von lungenkrankheiten mit optisch reinem s-salmeterol

Info

Publication number
ATE268166T1
ATE268166T1 AT98944834T AT98944834T ATE268166T1 AT E268166 T1 ATE268166 T1 AT E268166T1 AT 98944834 T AT98944834 T AT 98944834T AT 98944834 T AT98944834 T AT 98944834T AT E268166 T1 ATE268166 T1 AT E268166T1
Authority
AT
Austria
Prior art keywords
salmeterol
compositions
treatment
optically pure
lung diseases
Prior art date
Application number
AT98944834T
Other languages
English (en)
Inventor
Thomas P Jerussi
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Application granted granted Critical
Publication of ATE268166T1 publication Critical patent/ATE268166T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT98944834T 1997-09-16 1998-09-10 Zusammenstellungen zur behandlung von lungenkrankheiten mit optisch reinem s-salmeterol ATE268166T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/931,636 US6254882B1 (en) 1997-09-16 1997-09-16 Methods and compositions for treating pulmonary disorders using optically pure (S)—salmeterol
PCT/US1998/018845 WO1999013867A1 (en) 1997-09-16 1998-09-10 Methods and compositions for treating pulmonary disorders using optically pure (s)-salmeterol

Publications (1)

Publication Number Publication Date
ATE268166T1 true ATE268166T1 (de) 2004-06-15

Family

ID=25461118

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98944834T ATE268166T1 (de) 1997-09-16 1998-09-10 Zusammenstellungen zur behandlung von lungenkrankheiten mit optisch reinem s-salmeterol

Country Status (19)

Country Link
US (1) US6254882B1 (de)
EP (1) EP1007008B1 (de)
JP (1) JP2001516715A (de)
KR (1) KR20010030610A (de)
CN (1) CN1270515A (de)
AT (1) ATE268166T1 (de)
AU (1) AU754275B2 (de)
BG (1) BG104240A (de)
BR (1) BR9812643A (de)
CA (1) CA2304265A1 (de)
CZ (1) CZ290394B6 (de)
DE (1) DE69824296T2 (de)
ES (1) ES2221991T3 (de)
HU (1) HUP0003488A3 (de)
IL (1) IL135022A0 (de)
NO (1) NO20001343D0 (de)
NZ (1) NZ503563A (de)
SK (1) SK3722000A3 (de)
WO (1) WO1999013867A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
PT1212089E (pt) * 1999-08-21 2006-08-31 Altana Pharma Ag Combinacao sinergica de roflumilast e salmeterol
GB9924992D0 (en) * 1999-10-21 1999-12-22 Glaxo Group Ltd Pharmaceutical aerosol formulations
EP1523976A3 (de) * 1999-11-23 2005-06-22 Glaxo Group Limited Pharmazeutische Formulierungen enthaltend Salmeterol
WO2003024396A2 (en) 2001-09-17 2003-03-27 Glaxo Group Limited Dry powder medicament formulations
US7378438B2 (en) * 2002-04-19 2008-05-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
EP1562975A2 (de) * 2002-10-25 2005-08-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Steroide welche gruppen zur nachahmung von superoxidase dismutase sowie stickoxid donorgruppen beinhalten und ihre verwendung in der darstellung von medikamenten
EP1624866A2 (de) * 2003-05-16 2006-02-15 Arriva Pharmaceuticals, Inc. Behandlung von atemwegserkrankungen durch inhalation von syntetischen matrix metalloprotease inhibitoren
WO2004112791A1 (ja) * 2003-06-23 2004-12-29 Kyowa Hakko Kogyo Co., Ltd. 肺疾患の治療および／または予防剤
PL1719507T3 (pl) * 2005-04-13 2010-12-31 Cipher Pharmaceuticals Inc Agoniści receptora beta2-adrenergicznego do leczenia chorób tkanki łącznej skóry
US9119777B2 (en) 2008-05-30 2015-09-01 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
US8415390B2 (en) * 2008-05-30 2013-04-09 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW6584A1 (en) 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
IL95936A (en) 1989-10-10 1996-01-19 Glaxo Group Ltd ) R (-) - (- Hydroxy- (A-]]] 6-) 4- Phenylbutoxy (xyl [amino] methyl [-1,3-benzenedimethanol, its preparation and pharmaceutical preparations containing it
GB9024366D0 (en) 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
GB9026005D0 (en) 1990-11-29 1991-01-16 Glaxo Group Ltd Drug material suitable for micronisation
GB9107196D0 (en) 1991-04-05 1991-05-22 Sandoz Ag Improvements in or relating to organic compounds
NZ500250A (en) * 1997-04-30 2001-03-30 Bridge Pharma Inc Adrenergic beta-2 agonist eutomers, feed compositions and use for increasing muscle and decreasing fat

Also Published As

Publication number Publication date
EP1007008A1 (de) 2000-06-14
BG104240A (en) 2001-04-30
NO20001343L (no) 2000-03-15
HUP0003488A3 (en) 2003-05-28
US6254882B1 (en) 2001-07-03
DE69824296D1 (de) 2004-07-08
CZ290394B6 (cs) 2002-07-17
HUP0003488A2 (hu) 2001-02-28
NZ503563A (en) 2002-07-26
NO20001343D0 (no) 2000-03-15
SK3722000A3 (en) 2000-07-11
CZ2000916A3 (cs) 2000-08-16
ES2221991T3 (es) 2005-01-16
IL135022A0 (en) 2001-05-20
KR20010030610A (ko) 2001-04-16
EP1007008B1 (de) 2004-06-02
JP2001516715A (ja) 2001-10-02
BR9812643A (pt) 2000-08-22
AU754275B2 (en) 2002-11-07
EP1007008A4 (de) 2002-06-12
CN1270515A (zh) 2000-10-18
WO1999013867A1 (en) 1999-03-25
AU9228398A (en) 1999-04-05
CA2304265A1 (en) 1999-03-25
DE69824296T2 (de) 2005-06-30

Similar Documents

Publication Publication Date Title
DE69133576D1 (de) Verfahren zur Herstellung von Enantiomerisch reine Beta-D-Dioxolan-Nukleoside
ATE268166T1 (de) Zusammenstellungen zur behandlung von lungenkrankheiten mit optisch reinem s-salmeterol
DE69118359D1 (de) Optisch reines r(-)albuterol zur behandlung von asthma
DK144694A (da) Fremgangsmåde til fremstilling af en optisk ren enantiomer af formoterol
DE59608829D1 (de) Verfahren zur Herstellung von 1,3-Dimethyl-5-fluor-pyrazol-4-carboxaniliden
DK0787715T3 (da) Fremgangsmåde til racematspaltning af tramadol
DE69635305D1 (de) Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma
DE69502675D1 (de) Verfahren zur Herstellung von Bis(Aminomethyl)Cyclohexan
DE69828191D1 (de) Verfahren zur herstellung von 2,6-dialkylnaphthalin
ATE397088T1 (de) Verfahren zur herstellung von (s)- oder (r)-3,3,3-trifluor-2-hydroxy-2-methylpropionsaü e
ATE232387T1 (de) Verwendung eines inositoltriphosphatester, zur herstellung eines medikamentes
DE69717205D1 (de) Verfahren zur Herstellung von Wasserstoff enthaltenden fluorinierten Alkanen
DE50309260D1 (de) Verfahren zur herstellung von bicalutamid
DE59601601D1 (de) Verfahren zur Reindarstellung von trans- und cis-4-Hydroxy-2,2,6-trimethyl-cyclohexan-1-on aus Isomerengemischen
DE59600661D1 (de) Verfahren zur Herstellung von d,I-Menthol
ATE411281T1 (de) Verfahren zur herstellung von s-aryl-cystein
ATE339423T1 (de) Verfahren zur herstellung von 4'-o-substituierten 4'-demethyl-1 desoxypodophyllotoxinderivaten und geometrischen isomeren davon ,und antikrebspräparat, das diese enthält
DE69009394D1 (de) Verfahren zur Herstellung von 3-Cyano-3,5,5-trimethyl-1-cyclohexanon.
DE69410222D1 (de) Verfahren zur Herstellung von optisch aktiven Erythro-3-amino-1,2-epoxy-Verbindungen
DE59802620D1 (de) Verfahren zur Herstellung von trans-(R,R)-Actinol
DE69223880D1 (de) Verfahren zur Herstellung von gereinigtem 3,4-Epoxycyclohexyl-Methyl (Meth)Acrylat .
DE69802329D1 (de) Verfahren zur Herstellung von 3,4 disubstituirten Dinitroanilinen
DE69107897D1 (de) Verfahren zur Herstellung von N,N'-bis(tetrabromophthalimid).
DE60201223D1 (de) Verfahren zur Herstellung von 3,4-Dihydroxybenzonitril
DE69718690D1 (de) Verfahren zur Herstellung von optisch-aktivem 2-halogen-1-(substituiertes Phenyl)ethanol.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties